NL8900525A - Geneesmiddelen die sufotidine bevatten alsmede de toepassing daarvan. - Google Patents

Geneesmiddelen die sufotidine bevatten alsmede de toepassing daarvan. Download PDF

Info

Publication number
NL8900525A
NL8900525A NL8900525A NL8900525A NL8900525A NL 8900525 A NL8900525 A NL 8900525A NL 8900525 A NL8900525 A NL 8900525A NL 8900525 A NL8900525 A NL 8900525A NL 8900525 A NL8900525 A NL 8900525A
Authority
NL
Netherlands
Prior art keywords
sufotidine
piroxicam
steroidal anti
pharmaceutical preparation
free base
Prior art date
Application number
NL8900525A
Other languages
English (en)
Dutch (nl)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NL8900525A publication Critical patent/NL8900525A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NL8900525A 1988-03-04 1989-03-03 Geneesmiddelen die sufotidine bevatten alsmede de toepassing daarvan. NL8900525A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888805268A GB8805268D0 (en) 1988-03-04 1988-03-04 Medicaments
GB8805268 1988-03-04

Publications (1)

Publication Number Publication Date
NL8900525A true NL8900525A (nl) 1989-10-02

Family

ID=10632893

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8900525A NL8900525A (nl) 1988-03-04 1989-03-03 Geneesmiddelen die sufotidine bevatten alsmede de toepassing daarvan.

Country Status (12)

Country Link
JP (1) JP2834175B2 (de)
KR (1) KR890014110A (de)
AU (1) AU3098489A (de)
BE (1) BE1002256A3 (de)
DE (1) DE3906884A1 (de)
DK (1) DK104489A (de)
FR (1) FR2627985A1 (de)
GB (2) GB8805268D0 (de)
IT (1) IT8947714A0 (de)
NL (1) NL8900525A (de)
SE (1) SE8900752L (de)
ZA (1) ZA891640B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO300260B1 (no) 1993-05-05 1997-05-05 Torgersen Hans & Soenn Bilbarnestol
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
CA2379605C (en) * 1999-09-24 2007-06-26 Alcon, Inc. Topical suspension formulations containing ciprofloxacin and dexamethasone
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
KR20110079641A (ko) 2008-09-09 2011-07-07 아스트라제네카 아베 제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법
AU2010263304A1 (en) 2009-06-25 2012-02-02 Astrazeneca Ab Method for treating a patient at risk for developing an NSAID-associated ulcer
EP2797600A4 (de) 2011-12-28 2015-09-16 Pozen Inc Verbesserte zusammensetzungen und verfahren zur abgabe von omeprazol und acetylsalicylsäure

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655104A5 (fr) * 1980-02-28 1986-03-27 Glaxo Group Ltd Derives heterocycliques triazoliques, procedes pour leur preparation et compositions pharmaceutiques les comportant.
CY1398A (en) * 1981-09-04 1987-12-18 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
BE894286A (fr) * 1981-09-04 1983-03-02 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5-((3-(3-(1-piperidinylmethyl)phenoxy)-propyl)amino -1h-1,2,4-triazole-3-methanol ou un sel de ce compose
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs

Also Published As

Publication number Publication date
JP2834175B2 (ja) 1998-12-09
DK104489A (da) 1989-09-05
JPH01316319A (ja) 1989-12-21
AU3098489A (en) 1989-09-07
GB8904879D0 (en) 1989-04-12
SE8900752D0 (sv) 1989-03-03
GB8805268D0 (en) 1988-04-07
DE3906884A1 (de) 1989-09-14
GB2216413A (en) 1989-10-11
DK104489D0 (da) 1989-03-03
SE8900752L (sv) 1989-09-05
IT8947714A0 (it) 1989-03-03
KR890014110A (ko) 1989-10-21
FR2627985A1 (fr) 1989-09-08
ZA891640B (en) 1990-03-28
BE1002256A3 (fr) 1990-11-06

Similar Documents

Publication Publication Date Title
US20210113469A1 (en) Sustained release compositions using wax-like materials
US6544556B1 (en) Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
KR100483870B1 (ko) 양성자펌프억제제및비스테로이드성항염증약물을포함하는경구제약제형
AU606149B2 (en) Pharmaceutical formulations
EP1135121A2 (de) Kombination von duloxetin mit nichtsteroid-entzündungshemmern für die behandlung von schmerz
GB2105193A (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
AP324A (en) Medicaments for treating inflammatory conditions or for analgiesia.
US20110086074A1 (en) Combinations of niacin and an oxicam
NL8900525A (nl) Geneesmiddelen die sufotidine bevatten alsmede de toepassing daarvan.
KR0175345B1 (ko) 장점막 장애 예방 및 치료제
NL193821C (nl) Farmaceutisch preparaat.
JPH0296525A (ja) 医薬
WO2016130094A1 (en) A pharmaceutical composition containing ibuprofen, pseudoephedrine and vitamin c
CA1315690C (en) Synergistic combination of decarboxylase inhibitors and l-dopa pellets
JPS5921615A (ja) 鎮痛剤組成物
JP2015514799A (ja) サルサレートの遅延放出性医薬組成物
EP0182569B1 (de) Anwendung von 1,6-Dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4H-pyrido[1,2-a]pyrimidin-3-carboxamid zur Vorbeugung und Behandlung von Gastrointestinalschäden
SK19192000A3 (sk) Použitie paroxetínu alebo jeho farmaceuticky prijateľnej soli alebo solvátu na podporu odvykania od fajčenia alebo na zníženie alebo prevenciu relapsu fajčenia
GB2105588A (en) Pharmaceutical compositions containing non-steroidal anti- inflammatory agents
JP4430312B2 (ja) 医薬製剤
MXPA00012626A (en) Method of treatment
BRPI0707736A2 (pt) formulaÇÕes de imidazolilalquil-piridinas de dosagem estÁvel

Legal Events

Date Code Title Description
BV The patent application has lapsed